Cullinan Oncology, Inc. (CGEM) NASDAQ

9.00

+0.255(+2.92%)

Updated at June 06 01:16PM

Currency In USD

Valuation

Market Cap654.93M
Enterprise Value574.08M
P/E Ratio-2.88
PEG Ratio-0.75
Price/Sales Ratio0
Price/Book Ratio0.93
Enterprise/Revenue0
Enterprise/EBITDA-2.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.29

Income Statement

Revenue0
Revenue/Share0
Gross Profit-306,000
EBITDA-167.15M
Net Income-167.38M
Diluted EPS-3.11

Balance Sheet

Total Cash303.83M
Total Cash/Share5.16
Total Debt1.84M
Total Debt/Equity0
Current Ratio11.62
Book Value Per Share9.37

Price History

52-Week Change-61.22
52-Week High24.76
52-Week Low6.85
Moving Average 50 Days7.95
Moving Average 200 Days11.98

Statistics

Average Volume456,882
Shares Outstanding59.01M
% Held by Institutions109.77

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A